ANNAPOLIS, Md., June 20, 2024 (GLOBE NEWSWIRE) -- The state of Maryland continues to expand access to crucial healthcare services. RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services, made public statements to Maryland state committees in support of three bills on breast and lung screening. Maryland Governor Wes Moore recently signed those bills into state law, expanding residents' access to affordable, preventive healthcare. House ...

To that end, stocks like G-III Apparel Group, Ltd. (GIII) , RadNet, Inc. (RDNT) and Hess Corporation (HES) have been selected as the momentum picks for the day using the Driehaus strategy. Regarding the strategy, Driehaus once said: "I would much rather invest in a stock that's increasing in price and take the risk that it may begin to decline than invest in a stock that's already in decline and try to guess when it will turn around." In line with this insight, the American Association of Individual Investo ...

Core Insights - RadNet, Inc. is a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of outpatient imaging centers [3] - The company will present at the Sidoti & Company 2024 Small Cap Conference on June 12, 2024, at 12:15 p.m. Eastern Time [1][3] Company Overview - RadNet operates a network of 375 owned and/or operated outpatient imaging centers across several states including California, Maryland, Delaware, New Jersey, New York, Florida, Texas, and Arizona [3] - The company is recognized as the leading national provider of freestanding, fixed-site diagnostic imaging services in the U.S. based on the number of locations and annual imaging revenue [3] - RadNet employs over 9,700 individuals, including full-time and per diem employees and technologists [3]

Company Overview - RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States, based on the number of locations and annual imaging revenue [3] - The company operates a network of 375 owned and/or operated outpatient imaging centers across various states including California, Maryland, Delaware, New Jersey, New York, Florida, Texas, and Arizona [3] - RadNet employs over 9,700 individuals, including full-time and per diem employees and technologists [3] Upcoming Presentation - Mark Stolper, Executive Vice President and Chief Financial Officer of RadNet, will present at the Sidoti & Company 2024 Small Cap Conference on June 12, 2024, at 12:15 p.m. Eastern Time [1][3] - The presentation will be available via simultaneous and archived webcasts [2]

LOS ANGELES, June 07, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024 at 8:40 a.m. Eastern Time. Details for RadNet's Presentation: RadNet, Inc. is t ...

There will be simultaneous and archived webcasts available at https://urldefense.com/v3/__https://cc.webcasts.com/gold006/061024a_js/? entity=121_NWSYN1N__;!!COmMWt7_Sw!V66l0ZG5cxYwypkaKEI83IPMf5nghGoOxlElZW2FvPr2gR8n8oFoqWg8l4i9k_HD-P52j863_WQru8kCIE$ and www.radnet.com under the "News and Press Releases" sub-menu of the website. Date: Monday, June 10, 2024 Time: 8:40 a.m. Eastern Time Location: Miami, FL RadNet, Inc. is the leading national provider of freestanding, fixed-site diagnostic imaging services ...

Core Viewpoint - RadNet (RDNT) has experienced significant stock price appreciation, with a 20.6% increase over the past month and a 75.6% rise since the beginning of the year, outperforming the broader medical sector and the outpatient and home healthcare industry [1][2]. Financial Performance - For the current fiscal year, RadNet is projected to achieve earnings of $0.59 per share on revenues of $1.77 billion, reflecting an 18% increase in EPS and a 9.22% increase in revenues [2]. - In the next fiscal year, earnings are expected to rise to $0.64 per share on revenues of $1.89 billion, indicating a year-over-year change of 7.91% in EPS and 7.29% in revenues [2]. Valuation Metrics - RadNet's stock trades at a high valuation of 103.5X current fiscal year EPS estimates, significantly above the peer industry average of 22.9X [4]. - On a trailing cash flow basis, RadNet trades at 18.3X compared to the peer group's average of 13.2X, suggesting a premium valuation [4]. - The company has a Value Score of C, a Growth Score of B, and a Momentum Score of C, resulting in a combined VGM Score of B [12]. Zacks Rank and Style Scores - RadNet holds a Zacks Rank of 2 (Buy), supported by rising earnings estimates, which positions it favorably for potential investment [5][13]. - The Zacks Style Scores provide a framework for investors to evaluate stocks based on individual investment styles, with RadNet showing solid scores in Growth and Momentum [3]. Industry Context - The Medical - Outpatient and Home Healthcare industry is performing well, ranking in the top 19% of all industries, which provides a favorable backdrop for RadNet and its peers [7]. - Encompass Health Corporation (EHC), a competitor, has also shown strong performance, with a Zacks Rank of 2 (Buy) and positive earnings expectations [6][14].

Here are three of the most important factors that make the stock of this operator of medical diagnostic imaging centers a great growth pick right now. Earnings Growth Earnings growth is arguably the most important factor, as stocks exhibiting exceptionally surging profit levels tend to attract the attention of most investors. For growth investors, double-digit earnings growth is highly preferable, as it is often perceived as an indication of strong prospects (and stock price gains) for the company under con ...

1 IF D H HT T 100 - 100 1 i T 1 Pgiam/iStock via Getty Images Investment Summary Shares of RadNet, Inc. (NASDAQ:RDNT) continue to offer extensive appeal to unlock risk capital for quality-oriented investors. Since my last publication on the company in July last year, the equity line has curled up more than 88%, and the position has compounded by 184% cumulatively since I first bought it for our portfolios in 2022. RadNet 12-month share price evolution Seeking Alpha RNDT's management is deploying capital at ...

Core Viewpoint - RadNet (RDNT) has received an upgrade to a Zacks Rank 1 (Strong Buy), indicating a positive outlook for the company's earnings and potential stock price movement [1][2]. Earnings Estimates and Stock Price Impact - The upward trend in earnings estimates is a significant factor influencing stock prices, with a strong correlation between earnings estimate revisions and near-term stock movements [3][5]. - Institutional investors utilize earnings estimates to determine the fair value of a company's shares, impacting their buying and selling decisions, which in turn affects stock prices [3]. RadNet's Earnings Outlook - RadNet is projected to earn $0.59 per share for the fiscal year ending December 2024, reflecting an 18% year-over-year increase [7]. - Over the past three months, the Zacks Consensus Estimate for RadNet has risen by 34.1%, indicating a positive trend in earnings expectations [7]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [6]. - Only the top 5% of Zacks-covered stocks receive a 'Strong Buy' rating, suggesting that RadNet's upgrade places it among the best candidates for market-beating returns [8][9].